The ISCT Institute of Training & Development celebrates the Successful Completion of " Hands-on Methods and Analytical Processes for Cell and Gene Therapy Bioprocessing" – and its second site for Hands-on Training in the USA The ISCT Institute of Training & Development has...
Amine Bendahou, PhD Training and Education Specialist ISCT Head Office The ISCT Institute of Training & Development is thrilled to announce the launch of the 2025 ISCT Cell Therapy Leadership Training Program —a premier initiative designed to develop the next generation of...
Nisa Renault, PhD Research & Development Associate Director FUJIFILM Cellular Dynamics Madison, Wisconsin, USA The Telegraft Editorial Board is excited to present another live Member Spotlight feature for the July issue. Telegraft editor Dr. Ashley Krull, Ph.D., sat down at the 2024...
Interviewed by: Ashley Krull, Ph.D. Telegraft Contributing Editor Mayo Clinic Rochester United States Featuring: Evan B. Wilker, BS – Project Manager for CTL Hillary Bradbury, MLS(ASCP) – Operations Director for CTL Beth Daneault, MLS(ASCP) – Laboratory Manager for...
Sai Kiang Lim, PhD Principal Investigator A*STAR Institute of Molecular & Cell Biology Singapore Ashley Krull, Ph.D. Associate Director, Cell Therapy Manufacturing and Engineering Assistant Professor, Division of Hematology BMT/Cell Therapy Team United...
ISCT would like to extend its congratulations to Bruce Levine, Ph.D., ISCT Past President, on receiving the 2023 ASGCT Jerry Mendell Award for Translational Science. The Jerry Mendell Award for Translational Science recognizes those who have dedicated extensive work to bring gene and cell...
Interviewed by: Ashley Krull, Ph.D. Telegraft Contributing Editor Mayo Clinic Rochester Rochester, United States Featured Member: Jennifer Hollands Government and Academic Liaison Cell Therapies Peter MacCallum Cancer Centre Melbourne, Victoria, Australia Dr. Jennifer Hollands...
1 Comment - no search term matches found in comments.
by Gaurav Sutrave, B Sc(Med), MBBS, PhD Staff Specialist Haematologist Westmead Hospital Sydney, Australia The clinical success of CD19 specific chimeric antigen receptor (CAR) T cells and subsequent regulatory approvals for their use in the treatment of relapsed and refractory B cell...
By:Ashley Krull, Ph.D. Telegraft Contributing Editor Mayo Clinic Rochester Rochester, United States Featured Member: Bernd Giebel, Ph.D. Institute for Transfusion Medicine University Hospital Essen University of Duisburg-Essen Essen, Germany Article Dr. Bernd Giebel directs a...
Meet the Investor Brought to you by the ISCT Business Development & Finance Committee Bryan Poltilove Operating Partner BroadOak Capital Partners As Operating Partner with BroadOak, Mr. Poltilove leads the firm’s investments in Cell and Gene...